Abstract
Pregnant women and their fetuses are increasingly likely to be exposed to antipsychotics. However, safety data remain limited. This editorial suggests that, in future, well-designed observational pharmaco-epidemiology is our best chance of illuminating risk for exposed populations and of informing decision-making for women and clinicians.
MeSH terms
-
Abnormalities, Drug-Induced / etiology
-
Antipsychotic Agents / adverse effects*
-
Cohort Effect
-
Developmental Disabilities / chemically induced
-
Female
-
Forecasting
-
Humans
-
Maternal Exposure
-
Medication Adherence
-
Mental Disorders / drug therapy
-
Pregnancy
-
Pregnancy Complications / drug therapy
-
Pregnancy Outcome
-
Prenatal Exposure Delayed Effects / chemically induced*
-
Risk Factors